Mucormycosis risk factors: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
** AIDS
** AIDS
** Severe lymphocytopenia
** Severe lymphocytopenia
** Malignancy
** Malignancy <ref name="pmid24476149">{{cite journal |vauthors=Binder U, Maurer E, Lass-Flörl C |title=Mucormycosis--from the pathogens to the disease |journal=Clin. Microbiol. Infect. |volume=20 Suppl 6 |issue= |pages=60–6 |year=2014 |pmid=24476149 |doi=10.1111/1469-0691.12566 |url=}}</ref>


* Dialysis patients on Iron chelation therapy (deferoxamine).
* Dialysis patients on Iron chelation therapy (deferoxamine).
* Conatct with contaminated surgical instruments.
* Conatct with contaminated surgical instruments.
* Major trauma <ref name="pmid24476149">{{cite journal |vauthors=Binder U, Maurer E, Lass-Flörl C |title=Mucormycosis--from the pathogens to the disease |journal=Clin. Microbiol. Infect. |volume=20 Suppl 6 |issue= |pages=60–6 |year=2014 |pmid=24476149 |doi=10.1111/1469-0691.12566 |url=}}</ref>
* Iron overload  
* Iron overload  
* Aluminium overload <ref name="pmid9230837">{{cite journal |vauthors=McNab AA, McKelvie P |title=Iron overload is a risk factor for zygomycosis |journal=Arch. Ophthalmol. |volume=115 |issue=7 |pages=919–21 |year=1997 |pmid=9230837 |doi= |url=}}</ref>
* Aluminium overload <ref name="pmid9230837">{{cite journal |vauthors=McNab AA, McKelvie P |title=Iron overload is a risk factor for zygomycosis |journal=Arch. Ophthalmol. |volume=115 |issue=7 |pages=919–21 |year=1997 |pmid=9230837 |doi= |url=}}</ref>
==References==


{{WH}}{{WS}}
{{WH}}{{WS}}

Revision as of 22:05, 24 May 2017

Mucormycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mucormycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

Risk factors

The following conditions predispose patients to mucormycosis:
  • Immunodeficient states.
    • Transplant recepients
    • Diabetes (including diabetic ketoacidosis)
    • AIDS
    • Severe lymphocytopenia
    • Malignancy [1]
  • Dialysis patients on Iron chelation therapy (deferoxamine).
  • Conatct with contaminated surgical instruments.
  • Major trauma [1]
  • Iron overload
  • Aluminium overload [2]

References

Template:WHTemplate:WS

  1. 1.0 1.1 Binder U, Maurer E, Lass-Flörl C (2014). "Mucormycosis--from the pathogens to the disease". Clin. Microbiol. Infect. 20 Suppl 6: 60–6. doi:10.1111/1469-0691.12566. PMID 24476149.
  2. McNab AA, McKelvie P (1997). "Iron overload is a risk factor for zygomycosis". Arch. Ophthalmol. 115 (7): 919–21. PMID 9230837.